Pages that link to "Q34610688"
Jump to navigation
Jump to search
The following pages link to Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). (Q34610688):
Displaying 33 items.
- Neuroendocrine immunoregulation in multiple sclerosis (Q26864449) (← links)
- Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration (Q27023974) (← links)
- An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation (Q28593440) (← links)
- Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination (Q30479247) (← links)
- Resveratrol, 4' Acetoxy Resveratrol, R-equol, Racemic Equol or S-equol as Cosmeceuticals to Improve Dermal Health (Q33838655) (← links)
- Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes (Q33929484) (← links)
- Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis (Q34260259) (← links)
- Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. (Q34591580) (← links)
- Matrix metalloproteinases, synaptic injury, and multiple sclerosis (Q34689554) (← links)
- Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model. (Q35224674) (← links)
- Sex-related factors in multiple sclerosis susceptibility and progression (Q35619427) (← links)
- Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis (Q35954062) (← links)
- Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis (Q36653657) (← links)
- The role of estrogens in control of energy balance and glucose homeostasis (Q36864744) (← links)
- Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis (Q37194323) (← links)
- Female reproductive issues in multiple sclerosis (Q38021743) (← links)
- Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome (Q38511940) (← links)
- The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future. (Q38783057) (← links)
- Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application. (Q38921991) (← links)
- Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. (Q40888898) (← links)
- Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis (Q43517245) (← links)
- Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding (Q46145241) (← links)
- Estrogen inhibits estrogen receptor α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats (Q46151773) (← links)
- ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. (Q46762520) (← links)
- Effects of estrogen replacement therapy on the myelin sheath ultrastructure of myelinated fibers in the white matter of middle-aged ovariectomized rats (Q47283993) (← links)
- ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid (Q48101748) (← links)
- Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis (Q48738800) (← links)
- Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: an evaluation using visual evoked potential, marker genes expression and myelin staining. (Q51456650) (← links)
- Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis. (Q53173976) (← links)
- Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6. (Q53191163) (← links)
- Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry (Q58704396) (← links)
- "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era (Q92445909) (← links)
- ERβ-selective agonist alleviates inflammation in a multiple sclerosis model via regulation of MHC II in microglia (Q92512115) (← links)